Experimental drug offers promise in fight against measles
Published on Apr 17, 2014 6:35 AM
WASHINGTON (AFP) - An experimental anti-viral drug taken orally could help contribute to the eradication of measles, an infection responsible for thousands of deaths per year, scientists said in a report on Wednesday.
The drug, so far tested on animals, has been effective on a virus closely related to the one that causes measles, having reduced virus levels and prevented death.
Despite major progress to contain the highly-contagious disease worldwide, measles has caused around 150,000 deaths annually since 2007, according to the study, which appeared in the journal Science Translational Medicine.
A European resurgence of the measles-causing morbillivirus, previously considered contained on that continent, is due in large part to insufficient vaccination rates, mostly because parents opt out of vaccinating their children.
To continue reading, log in if you are a subscriber
If you are not a subscriber, you can get instant, unlimited access here